S236: RANDOMIZED MULTICENTER PHASE III STUDY OF HAPLO VERSUS HLA-MATCHED UNRELATED DONOR (UD) ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO HSCT) FOR PATIENTS OLDER THAN 55 YEARS

• S. Harbi,
• J.-M. Boher,
• E. Forcade,
• P. Chevallier,
• R. Peffault De Latour,
• F. Malard,
• S. Francois,
• A. Charbonnier,
• E. Hermet,
• C. E. Bulabois,
• A. Huynh,
• A. Berceanu,
• T. Cluzeau,
• M. T. Rubio,
• S. Furst,
• R. devillier,
• M. Mohty,
• D. Blaise

Affiliations

S. Harbi

1 hematology

J.-M. Boher

2 DRCI, Institut Paoli Calmettes, Marseille

E. Forcade

3 hematology, CHU, Bordeaux

P. Chevallier

4 hematology, CHU, Nantes

R. Peffault De Latour

5 Transplant Unit, Hopital Saint Louis

F. Malard

6 hematology, Hopital Saint Antoine, Paris

S. Francois

7 hematology, CHU, Angers

A. Charbonnier

8 hematology, CHU, Amiens

E. Hermet

9 hematolgy, CHU, Clermont Ferrand

C. E. Bulabois

10 hematolgy, CHU, Grenoble

A. Huynh

11 hematology, CHU, Toulouse

A. Berceanu

12 hematology, CHU, besancon

T. Cluzeau

13 hematology, CHU, Nice

M. T. Rubio

14 hematology, CHU, Nancy

S. Furst

1 hematology

R. devillier

15 hematolgy, Institut Paoli Calmettes, Marseille, France

M. Mohty

6 hematology, Hopital Saint Antoine, Paris

D. Blaise

1 hematology